Navigation Links
Anti-Microbial Coating For Use Over Biomedical Devices Developed

The application of anti-microbial coating over artificial implants such as hip, knee implants and catheters have been found to reduce the infection rates following surgery. // This would indirectly be associated with a significant reduction in the health care cost and an improvement in the quality of life of the patients.

Following surgery, the implantable devices are prone for infection. In a majority of the cases, such infections cannot be managed by using commonly available antibiotics. This necessitates the need for a second surgery to remove the implant from the site of infection to be followed by cleansing of the infected wound and a second replacement.

Another major source for acquired infections is the catheter, commonly placed inside the body for urinary drainage. These devices can spread the bacterial infections from the skin to the site of incision. Under rare conditions, it has also been known to cause anaphylactic shock, leading to death. Potential infections due to long term use of catheters are minimized by removal and replacement of the catheter at frequent intervals. This again means an additional expense for the patient.

Some of these bacteria that are present on medical devices even settle on contact lenses, leading to eye infection and inflammation.

Nanometer size (of the order of 10-9 m) coatings are currently being developed to be used over biomedical implants and devices to prevent bacterial infection and colonisation that would otherwise lead to sepsis. Following the finding that molecules called furanones (naturally occurring compound, extracted from algae) can prevent bacterial and fungal colonisation; attempts are being made to incorporate these compounds as a form of coating over biomedical devices.

As soon as bacteria adhere to any surface, they anchor themselves strongly by reaching out to other bacteria with the release of chemical called homoserine lactones. This enables the bacteria t
'"/>




Page: 1 2

Related medicine news :

1. Misuse Of Anti-Microbial Drugs Have Given Rise To Multidrug-resistant TB Strains
2. Aloe Vera Coating For Fruits And Vegetables Preservation
3. Antiviral Coating On Bank Notes, Photocopiers Could Help Check Epidemics
4. Edible Food Coating Kills Bacteria And Adds Flavor
5. Chicago :FDA imposes Ban on Biomedical Tissue Services
6. HIV Infected Body Parts Stolen: Biomedical Tissue Services To Face Legal Action
7. New Biomedical Device to Monitor Hip Implant Healing
8. Injection supports Heart Devices
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Making MRIs Safe for Patients With Implantable Heart Devices
11. Scientists Concerned Over Increasing Malfunction Of Heart Devices
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... follows weight pattern in France reveals that Fre...and fatter//. According to the ObEpi-Roche survey...5 years is affected by weight problem, with 1/3rd ... obese.Obesity is on a high in France, in spite of...
...the next school year will probably see a promotion...le to apply for a chunk// of a $3-million-a-year N... $12 million Nutrition Fund as part of its support... Government. Schools and early childhood centers...
...earchers suggest a short-term application of topic...ent agent for patients// with intertriginous psori...eptember issue of Archives of Dermatology, one of ... is an inflammatory skin disease. In a subset of ...
...researchers at Manchester University, hearing voic...ses the traditional belief//. A Dutch report revea...n fact, several people who hear voices do not seek... voice has a positive effect on them by calming or...
Other Medicine News:Health News:Obesity on a high in France 2Health News:Better Nutrition in Schools Boosted by $12m Fund 2Health News:Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis 2Health News:Hearing voices may be normal 2
(Date:10/9/2008)...al Results Expected in November 2008, BOTHELL, Wa..., Inc.,(Amex: DDD ) announced today the completio...f its three pivotal trials to evaluate the safety ...d-release (ER) ibuprofen for,the over-the-counter ...ne,results from this pivotal trial in November 200...
(Date:10/8/2008)...Someday Inform Treatments for Spinal Cord, Other N...-USNewswire/ -- A protein that enables,nerve cells...n controlling,the developing nervous system. Resea...s to form among nerve cells may provide a basis fo...ries to their nervous system,including spinal cor...
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/7/2008)... efficacy of new device for detecting polyps that ...copy, ORLANDO, Fla., Oct. 7 /- At th...ntific Meeting in Orlando (ACG 2008), renowned,gas...ts from a,multi-institutional clinical study that ...ope(R), a new device that is designed to improve t...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Preeclampsia Linked to Heart Disease Risk 5393 1Preeclampsia Linked to Heart Disease Risk 5393 2Preeclampsia Linked to Heart Disease Risk 5393 3Cornell will host the Northeast Biofuel Summit Nov 11 13 1087 1Mannatech Hosts Australasian Convention 5389 1Mannatech Hosts Australasian Convention 5389 2Mannatech Hosts Australasian Convention 5389 3American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 1American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 2American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 3
... 8, 2007 - Late-breaking Phase III,clinical trial ...ety on Thrombosis and Haemostasis (ISTH) Congress ...uperior efficacy in the,prevention of venous throm...cement surgery in a head-to-head comparison with,e...in the RECORD3,(REgulation of Coagulation in major...
...ess with Positive Phase IIa Clinical,Trial Results...lication of Key,Product in AM-Pharma,s Pipeline , ...V., the,biopharmaceutical company developing novel... diseases, today announced the positive,clinical r...trial,for patients with ulcerative colitis, a chro...
Other Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: